Trial Outcomes & Findings for Safety and Effectiveness of the Peregrine Drivable ENT Scope for Endoscopy of the Paranasal Sinuses (NCT NCT04096482)

NCT ID: NCT04096482

Last Updated: 2021-10-15

Results Overview

The ability of each endoscope type to visualize the maxillary sinus anatomy (ostium, floor, lateral recess, anterior wall) was assessed as being a success or failure.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

6 participants

Primary outcome timeframe

Day 1 (after each endoscopy)

Results posted on

2021-10-15

Participant Flow

Participants were recruited from Emory University Hospital Midtown in Atlanta, Georgia, USA. Participant enrollment began November, 5, 2019 and all follow up was complete by September 1, 2020.

Participant milestones

Participant milestones
Measure
Standard 30° 4mm Endoscope Followed by Peregrine Endoscope
Participants with prior endoscopic sinus surgery (EES) scheduled for nasal endoscopy who are receiving an endoscopy with the standard 30° 4mm endoscope followed by an endoscopy with the Peregrine Drivable Ear Nose and Throat (ENT) Scope.
Overall Study
STARTED
6
Overall Study
COMPLETED
6
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Safety and Effectiveness of the Peregrine Drivable ENT Scope for Endoscopy of the Paranasal Sinuses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Endoscope Followed by Peregrine Drivable ENT Scope
n=6 Participants
Participants with prior endoscopic sinus surgery (EES) scheduled for nasal endoscopy who are receiving an endoscopy with the standard 30° 4mm endoscope followed by an endoscopy with the Peregrine Drivable ENT Scope.
Age, Continuous
50.83 years
STANDARD_DEVIATION 17.73 • n=5 Participants
Sex: Female, Male
Female
4 Participants
n=5 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
Race (NIH/OMB)
White
2 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
6 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 1 (after each endoscopy)

The ability of each endoscope type to visualize the maxillary sinus anatomy (ostium, floor, lateral recess, anterior wall) was assessed as being a success or failure.

Outcome measures

Outcome measures
Measure
Peregrine Drivable ENT Scope
n=6 Participants
Participants receiving an endoscopy with the Peregrine Drivable ENT scope.
Standard 30° 4mm Endoscope
n=6 Participants
Participants receiving an endoscopy with the standard 30° 4mm endoscope.
Number of Participants With Visualization Success of Maxillary Sinus Anatomy
Left Ostium
6 Participants
6 Participants
Number of Participants With Visualization Success of Maxillary Sinus Anatomy
Right Ostium
6 Participants
6 Participants
Number of Participants With Visualization Success of Maxillary Sinus Anatomy
Left Floor
6 Participants
1 Participants
Number of Participants With Visualization Success of Maxillary Sinus Anatomy
Right Floor
4 Participants
0 Participants
Number of Participants With Visualization Success of Maxillary Sinus Anatomy
Left Lateral Recess
6 Participants
1 Participants
Number of Participants With Visualization Success of Maxillary Sinus Anatomy
Right Lateral Recess
5 Participants
1 Participants
Number of Participants With Visualization Success of Maxillary Sinus Anatomy
Left Anterior Wall
6 Participants
0 Participants
Number of Participants With Visualization Success of Maxillary Sinus Anatomy
Right Anterior Wall
4 Participants
0 Participants

PRIMARY outcome

Timeframe: Day 1 (after each endoscopy)

The ability of each endoscope type to visualize the frontal sinus anatomy (ostium, posterior table, anterior table, lateral recess) was assessed as being a success or failure.

Outcome measures

Outcome measures
Measure
Peregrine Drivable ENT Scope
n=6 Participants
Participants receiving an endoscopy with the Peregrine Drivable ENT scope.
Standard 30° 4mm Endoscope
n=6 Participants
Participants receiving an endoscopy with the standard 30° 4mm endoscope.
Number of Participants With Visualization Success of Frontal Sinus Anatomy
Right Posterior Table
3 Participants
3 Participants
Number of Participants With Visualization Success of Frontal Sinus Anatomy
Left Lateral Recess
2 Participants
0 Participants
Number of Participants With Visualization Success of Frontal Sinus Anatomy
Right Lateral Recess
1 Participants
0 Participants
Number of Participants With Visualization Success of Frontal Sinus Anatomy
Left Ostium
6 Participants
6 Participants
Number of Participants With Visualization Success of Frontal Sinus Anatomy
Right Ostium
6 Participants
6 Participants
Number of Participants With Visualization Success of Frontal Sinus Anatomy
Left Posterior Table
4 Participants
3 Participants
Number of Participants With Visualization Success of Frontal Sinus Anatomy
Left Anterior Table
4 Participants
2 Participants
Number of Participants With Visualization Success of Frontal Sinus Anatomy
Right Anterior Table
3 Participants
2 Participants

PRIMARY outcome

Timeframe: Day 1 (after each endoscopy)

The ability of each endoscope type to visualize the sphenoid sinus anatomy (ostium, sella, floor, lateral aspect) was assessed as being a success or failure.

Outcome measures

Outcome measures
Measure
Peregrine Drivable ENT Scope
n=6 Participants
Participants receiving an endoscopy with the Peregrine Drivable ENT scope.
Standard 30° 4mm Endoscope
n=6 Participants
Participants receiving an endoscopy with the standard 30° 4mm endoscope.
Number of Participants With Visualization Success of Sphenoid Sinus Anatomy
Left Ostium
6 Participants
5 Participants
Number of Participants With Visualization Success of Sphenoid Sinus Anatomy
Right Ostium
6 Participants
6 Participants
Number of Participants With Visualization Success of Sphenoid Sinus Anatomy
Left Sella
4 Participants
5 Participants
Number of Participants With Visualization Success of Sphenoid Sinus Anatomy
Right Sella
4 Participants
5 Participants
Number of Participants With Visualization Success of Sphenoid Sinus Anatomy
Left Floor
3 Participants
3 Participants
Number of Participants With Visualization Success of Sphenoid Sinus Anatomy
Right Floor
5 Participants
3 Participants
Number of Participants With Visualization Success of Sphenoid Sinus Anatomy
Left Lateral Aspect
4 Participants
2 Participants
Number of Participants With Visualization Success of Sphenoid Sinus Anatomy
Right Lateral Aspect
5 Participants
2 Participants

SECONDARY outcome

Timeframe: Day 1 (after each endoscopy)

Image quality will be assessed through a yes/no statement, reported by physicians, regarding the adequacy of the Peregrine image quality for making clinical decisions in the office setting.

Outcome measures

Outcome measures
Measure
Peregrine Drivable ENT Scope
n=6 Participants
Participants receiving an endoscopy with the Peregrine Drivable ENT scope.
Standard 30° 4mm Endoscope
Participants receiving an endoscopy with the standard 30° 4mm endoscope.
Number of Participants With Adequate or Inadequate Image Quality From Peregrine Endoscopy
Adequate image quality
4 Participants
Number of Participants With Adequate or Inadequate Image Quality From Peregrine Endoscopy
Inadequate image quality
2 Participants

SECONDARY outcome

Timeframe: Day 1 (after each endoscopy)

Participant tolerability was evaluated through validated VAS for both endoscopies. Scores range from 1 to 10, where 1 = highly tolerable and 10 = not tolerable.

Outcome measures

Outcome measures
Measure
Peregrine Drivable ENT Scope
n=6 Participants
Participants receiving an endoscopy with the Peregrine Drivable ENT scope.
Standard 30° 4mm Endoscope
n=6 Participants
Participants receiving an endoscopy with the standard 30° 4mm endoscope.
Visual Analogue Scale (VAS) Tolerability Score
1.98 score on a scale
Standard Deviation 1.72
2.52 score on a scale
Standard Deviation 3.66

SECONDARY outcome

Timeframe: Day 1 (after each endoscopy)

Participant pain was evaluated through validated VAS for both endoscopies. Scores range from 1 to 10, where 1 = no pain and 10 = pain as bad as it could be.

Outcome measures

Outcome measures
Measure
Peregrine Drivable ENT Scope
n=6 Participants
Participants receiving an endoscopy with the Peregrine Drivable ENT scope.
Standard 30° 4mm Endoscope
n=6 Participants
Participants receiving an endoscopy with the standard 30° 4mm endoscope.
VAS Pain Score
3.75 score on a scale
Standard Deviation 1.79
4.13 score on a scale
Standard Deviation 3.5

SECONDARY outcome

Timeframe: Day 1 (after each endoscopy)

The impact on clinical workflow of visual information obtained by each endoscope procedures was rated by physicians on a 5-point scale where 1 = worst and 5 = best.

Outcome measures

Outcome measures
Measure
Peregrine Drivable ENT Scope
n=6 Participants
Participants receiving an endoscopy with the Peregrine Drivable ENT scope.
Standard 30° 4mm Endoscope
n=6 Participants
Participants receiving an endoscopy with the standard 30° 4mm endoscope.
Impact on Clinical Workflow
3 score on a scale
Standard Deviation 1.55
5 score on a scale
Standard Deviation 0

SECONDARY outcome

Timeframe: Day 1 (after each endoscopy)

The ease of use of each endoscope procedure was rated by physicians on a 5-point scale where 1 = worst and 5 = best.

Outcome measures

Outcome measures
Measure
Peregrine Drivable ENT Scope
n=6 Participants
Participants receiving an endoscopy with the Peregrine Drivable ENT scope.
Standard 30° 4mm Endoscope
n=6 Participants
Participants receiving an endoscopy with the standard 30° 4mm endoscope.
Ease of Use
2.67 score on a scale
Standard Deviation 1.37
5 score on a scale
Standard Deviation 0

Adverse Events

Peregrine Drivable ENT Scope

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard 30° 4mm Endoscope

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Joshua M Levy

Emory University

Phone: (404) 778-3381

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place